...
首页> 外文期刊>Malaria Journal >Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions
【24h】

Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions

机译:在肯尼亚三个地区的儿童和成人中使用非处方疟疾药品:对私营药品零售商干预措施的影响

获取原文
           

摘要

Background Global malaria control strategies highlight the need to increase early uptake of effective antimalarials for childhood fevers in endemic settings, based on a presumptive diagnosis of malaria in this age group. Many control programmes identify private medicine sellers as important targets to promote effective early treatment, based on reported widespread inadequate childhood fever treatment practices involving the retail sector. Data on adult use of over-the-counter (OTC) medicines is limited. This study aimed to assess childhood and adult patterns of OTC medicine use to inform national medicine retailer programmes in Kenya and other similar settings. Methods Large-scale cluster randomized surveys of treatment seeking practices and malaria parasite prevalence were conducted for recent fevers in children under five years and recent acute illnesses in adults in three districts in Kenya with differing malaria endemicity. Results A total of 12, 445 households were visited and data collected on recent illnesses in 11, 505 children and 19, 914 adults. OTC medicines were the most popular first response to fever in children with fever (47.0%; 95% CI 45.5, 48.5) and adults with acute illnesses (56.8%; 95% CI 55.2, 58.3). 36.9% (95% CI 34.7, 39.2) adults and 22.7% (95% CI 20.9, 24.6) children using OTC medicines purchased antimalarials, with similar proportions in low and high endemicity districts. 1.9% (95% CI 0.8, 4.2) adults and 12.1% (95% CI 16.3,34.2) children used multidose antimalarials appropriately. Although the majority of children and adults sought no further treatment, self-referral to a health facility within 72 hours of illness onset was the commonest pattern amongst those seeking further help. Conclusion In these surveys, OTC medicines were popular first treatments for fever in children or acute illnesses in adults. The proportions using OTC antimalarials were similar in areas of high and low malaria endemicity. In all districts, adults were more likely to self-treat with OTC antimalarial medicines than febrile children were to receive them, and less likely to use them in recommended ways. Government health centres were the most common second resort for treatment and were often used within 72 hours. In view of these practices, more research is needed to assess the impact on the popularity of private medicine sellers of strengthened public sector policies on access to malaria treatment and insecticide-treated bed nets. Improved targeting of OTC antimalarials to high risk groups, better communication strategies regarding adult as well as children's dosages, and facilitating more rapid referral to trained health workers where needed are important challenges to private medicine seller programmes.
机译:背景技术全球疟疾控制策略强调,根据该年龄组的疟疾推定诊断,需要增加对流行性环境中儿童发烧的有效抗疟药的早期吸收。根据报道的涉及零售部门的广泛的不充分的儿童发烧治疗实践,许多控制计划将私人药品销售商确定为促进有效早期治疗的重要目标。关于成人使用非处方药的数据有限。这项研究旨在评估OTC药物在儿童和成人时期的使用情况,以为肯尼亚和其他类似国家的国家药品零售商计划提供信息。方法对不同疟疾流行地区的肯尼亚三个地区的5岁以下儿童最近出现的发烧和成年人最近出现的急性疾病进行了大规模的整群随机调查,包括寻求治疗的方法和疟疾寄生虫流行情况。结果总共访问了12 445户家庭,并收集了11 505名儿童和19 914名成人的近期疾病数据。 OTC药物是发烧儿童(47.0%; 95%CI 45.5、48.5)和成人急性疾病(56.8%; 95%CI 55.2、58.3)最常见的发烧第一反应。使用非处方药的成年人中有36.9%(95%CI 34.7,39.2)和22.7%(95%CI 20.9,24.6)儿童购买了抗疟药,在低和高流行地区的比例相似。 1.9%(95%CI 0.8,4.2)的成年人和12.1%(95%CI 16.3,34.2)的儿童适当地使用了多剂量抗疟药。尽管大多数儿童和成人没有寻求进一步的治疗,但在寻求进一步帮助的患者中,最常见的模式是在发病后72小时内自行转诊至医疗机构。结论在这些调查中,OTC药物是儿童发烧或成人急性疾病的流行首选治疗方法。在疟疾高发和低发地区,使用OTC抗疟药的比例相似。在所有地区,成年人比接受高热儿童接受OTC抗疟药自我治疗的可能性更高,并且以推荐的方式使用它们的可能性也较小。政府医疗中心是最常见的第二种治疗手段,经常在72小时内使用。鉴于这些做法,需要进行更多的研究,以评估加强公共部门关于获得疟疾治疗和经杀虫剂处理的蚊帐的公共政策对私营药品销售者的影响。更好地将OTC抗疟药针对高危人群,针对成人和儿童剂量的更好的沟通策略,以及在需要时促进更迅速地转介经过培训的医务人员,这是私人药品销售商计划的重要挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号